PRECISION PROFILES Trademark

Trademark Overview

On Tuesday, October 5, 1999, a trademark application was filed for PRECISION PROFILES with the United States Patent and Trademark Office. The USPTO has given the PRECISION PROFILES trademark a serial number of 75816056. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 12, 2013. This trademark is owned by Source Biopharmaceuticals, Inc.. The PRECISION PROFILES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

quantitative analysis of gene expression products, occurring in vivo and in vitro, using tools of molecular biology
precision profiles

General Information

Serial Number75816056
Word MarkPRECISION PROFILES
Filing DateTuesday, October 5, 1999
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 12, 2013
Registration Number2659985
Registration DateTuesday, December 10, 2002
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 12, 2002

Trademark Statements

Goods and Servicesquantitative analysis of gene expression products, occurring in vivo and in vitro, using tools of molecular biology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 12, 2013
Primary Code042
First Use Anywhere DateWednesday, December 8, 1999
First Use In Commerce DateWednesday, December 8, 1999

Trademark Owner History

Party NameSOURCE PRECISION MEDICINE, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301
Party NameSOURCE PRECISION MEDICINE, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBOULDER, CO 80301
Party NameSource Biopharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301
Party NameSource Biopharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Trademark Events

Event DateEvent Description
Friday, July 12, 2013CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Friday, March 2, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 2, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, November 22, 2008REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, November 12, 2008ASSIGNED TO PARALEGAL
Wednesday, November 5, 2008TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 4, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 4, 2008TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 3, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 3, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 27, 2008CASE FILE IN TICRS
Tuesday, December 10, 2002REGISTERED-PRINCIPAL REGISTER
Wednesday, October 2, 2002ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 4, 2002ASSIGNED TO EXAMINER
Thursday, August 29, 2002STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 29, 2002EXTENSION 1 GRANTED
Friday, July 26, 2002USE AMENDMENT FILED
Friday, July 26, 2002EXTENSION 1 FILED
Monday, July 29, 2002PAPER RECEIVED
Tuesday, June 4, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2002PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2002NOTICE OF PUBLICATION
Wednesday, November 14, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 28, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 26, 2000NON-FINAL ACTION MAILED
Saturday, December 23, 2000ASSIGNED TO EXAMINER
Wednesday, October 11, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 17, 2000NON-FINAL ACTION MAILED
Friday, February 25, 2000ASSIGNED TO EXAMINER
Wednesday, February 9, 2000ASSIGNED TO EXAMINER

Related Keywords

profiles precision using vitro tools molecular biology vivo occurring analysis gene expression